Utility model patents are simple, quick and cheap to file in China. They can also be used as a weapon against under-prepared foreign companies, for as long as 10 years.
China's M&A Rules effectively blocked domestic Chinese companies from raising money on overseas capital markets. But recent Ministry of Commerce guidelines may have provided a way out. By Zhou Jiaxing, Or & Partners, Hong Kong.
China continues to take steps towards unifying its approach to intellectual property with the development and codification of a national strategy. CLP presents an analysis of some of the biggest IP-related issues affecting those who do business in the PRC.
China continues to take steps towards unifying its approach to intellectual property with the development and codification of a national strategy. CLP presents an analysis of some of the biggest IP-related issues affecting those who do business in the PRC.
Amendments to China's insurance law have been under discussion for a decade. But some changes may have been rushed through to meet the demands of a struggling economy.
China's developing IP system faces some big tests in 2009. Janice Qu and Peter Ollier spoke with SIPO commissioner Tian Lipu about patent amendments, the National IP Strategy and the Office's global role
New measures covering the administration of outbound investment promise faster and simpler review of many small to medium-size PRC direct investments abroad, and more careful review of others. By Neal Stender, Lin Lawrence Zhou and Yan Zeng, of Orrick Herrington & Sutcliffe, Beijing, Hong Kong and Shanghai.
Two new sets of guidelines will further streamline the process for approval of foreign investments, but some additional restrictions have been added. By Jonathan Z Zhou, Jessica Xu and Kevin Troy, Fangda Partners.
China's revised insurance law clarifies many important details for insurance companies and gives more power to the regulator to deal with errant foreign institutions. By Chen Xin and Maarten Roos, Wang Jing & Co Shanghai Office.
China's rejection of Coca-Cola's bid for Huiyuan Juice on anti-monopoly grounds stirred debate on protectionism, and raised unwarranted concerns about future M&A activity in the country